Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVXL Anavex Life Sciences Corp.

休市中 08-23 16:00:00 EDT

6.32

+0.19

+3.10%

盘后6.32

+0.000.00%

18:51 EDT

最高6.50	最低6.15	成交量68.23万
今开6.17	昨收6.13	日振幅5.71%
总市值5.36亿	流通市值5.20亿	总股本8,480万
成交额432.90万	换手率0.83%	流通股本8,221万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVXL","market":"US","secType":"STK","nameCN":"Anavex Life Sciences Corp.","latestPrice":6.32,"timestamp":1724443200000,"preClose":6.13,"halted":0,"volume":682337,"hourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"18:51 EDT","volume":20903,"amount":132108.19,"timestamp":1724453497614},"delay":0,"floatShares":82205887,"shares":84795517,"eps":-0.501751,"marketStatus":"休市中","marketStatusCode":7,"change":0.19,"latestTime":"08-23 16:00:00 EDT","open":6.17,"high":6.5,"low":6.15,"amount":4328975.193232,"amplitude":0.057096,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.501751,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":6.13,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"18:51 EDT","volume":20903,"amount":132108.19,"timestamp":1724453497614},"volumeRatio":1.1374345569468096,"impliedVol":0.4312,"impliedVolPercentile":0.0873},"requestUrl":"/m/hq/s/AVXL/wiki","defaultTab":"wiki","newsList":[{"id":"2460244746","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460244746","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460244746?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:43","pubTimestamp":1723826611,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日00时43分，Anavex Life Sciences Corp.股票出现波动，股价快速下跌5.04%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.07%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700433197198fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700433197198fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2459189468","title":"Anavex Life Sciences Corp.盘中异动 快速上涨5.19%报6.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459189468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459189468?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:15","pubTimestamp":1723565753,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日00时15分，Anavex Life Sciences Corp.股票出现波动，股价大幅拉升5.19%。截至发稿，该股报6.48美元/股，成交量18.2256万股，换手率0.21%，振幅4.22%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为1.58%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814001553aefea12b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814001553aefea12b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2458978876","title":"Anavex Life Sciences Corp.2024财年第二财季实现净利润-12.21百万美元，同比减少8.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458978876","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458978876?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:15","pubTimestamp":1723392914,"startTime":"0","endTime":"0","summary":"8月12日，Anavex Life Sciences Corp.公布财报，公告显示公司2024财年第二财季净利润为-12.21百万美元，同比减少8.24%；其中营业收入为0.00美元，每股基本收益为-0.14美元。机构评级：截至2024年8月12日，当前有3家机构对Anavex Life Sciences Corp.目标价做出预测，其中目标均价为33.67美元，其中最低目标价为15.00美元，最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120015269f222975&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120015269f222975&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL"],"gpt_icon":0},{"id":"1156848130","title":"异动解读 | Anavex Life Sciences盘中大跌6%,新药研发前景存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=1156848130","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156848130?lang=zh_cn&edition=full","pubTime":"2024-08-11 23:16","pubTimestamp":1723389386,"startTime":"0","endTime":"0","summary":"生物制药公司Anavex Life Sciences Corp.今日盘中股价大跌6.02%,引发市场关注。分析人士认为,这可能与投资者对公司新药研发前景的担忧有关。Anavex Life Sciences是一家临床阶段的生物制药公司,专注于开发治疗阿尔茨海默病、帕金森病等中枢神经系统疾病的新疗法。然而,尽管公司在新药研发方面取得了一定进展,但目前仍处于临床阶段,距离上市销售还有一定距离。同时,公司最新财报显示,目前尚无营业收入,净利润为负值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2458597799","title":"Anavex Life Sciences Corp.盘中异动 早盘急速跳水5.12%报6.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458597799","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458597799?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:59","pubTimestamp":1723215560,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时59分，Anavex Life Sciences Corp.股票出现异动，股价急速跳水5.12%。截至发稿，该股报6.30美元/股，成交量11.945万股，换手率0.14%，振幅5.87%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为2.14%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809225920af96d51d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809225920af96d51d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1155302819","title":"异动解读 | Anavex Life Sciences盘中大涨5%,潜在新药研发前景受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1155302819","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155302819?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:06","pubTimestamp":1723190805,"startTime":"0","endTime":"0","summary":"生物制药公司Anavex Life Sciences Corp.今日盘中股价大涨5.08%,引发市场关注。尽管没有直接相关新闻解释这一涨幅的原因,但分析人士认为,公司在研发治疗中枢神经系统疾病新药方面的潜力或是推动股价上涨的主因。Anavex Life Sciences是一家临床阶段的生物制药公司,专注于开发治疗阿尔茨海默病、帕金森病等中枢神经系统疾病的新疗法。所有3家评级机构均给予AVXL股票\"买入\"评级,反映出对公司长期增长潜力的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2457312396","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅上涨5.09%报6.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457312396","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457312396?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:15","pubTimestamp":1723126533,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时15分，Anavex Life Sciences Corp.股票出现波动，股价快速拉升5.09%。截至发稿，该股报6.39美元/股，成交量12.7859万股，换手率0.15%，振幅4.61%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为2.01%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808221534941ff791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808221534941ff791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2457844264","title":"Anavex Life Sciences Corp.盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844264","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844264?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:35","pubTimestamp":1723037715,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时35分，Anavex Life Sciences Corp.股票出现波动，股价大幅上涨5.06%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.68%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213515af9668d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213515af9668d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1139644191","title":"异动解读 | Anavex Life Sciences盘中大涨5.58% 或受财报数据影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1139644191","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139644191?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:01","pubTimestamp":1722952893,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp.(AVXL)今日盘中股价大涨5.58%,报收6.81美元/股,引发市场关注。\n\n公司近期公布的最新季度财报显示,Anavex Life Sciences上季度调整后每股亏损14美分,与去年同期持平;营收为零,符合分析师预期。尽管业绩未现明显改善,但该公司股价在本季度内上涨了52.8%,表现强劲。\n\n分析人士指出,尽管财报数据平平,但投资者可能对公司在研发新药方面的进展抱有期待,从而支撑了股价上涨。不过,具体导致股价大涨的原因暂时仍不明确,有待进一步观察和分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2457023498","title":"Anavex 生命科学公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023498","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023498?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:52","pubTimestamp":1722952356,"startTime":"0","endTime":"0","summary":"   * Anavex Life Sciences Corp   报告，截至6月底的季度调整后每股亏损14美分，与去年同期持平。华尔街预期为每股-21美分至-12美分。* Anavex Life Sciences Corp 公布的季度每股收益为亏损 14 美分。* 该公司当季亏损 1221 万美元。* Anavex Life Sciences Corp 的股价本季度上涨了 52.8%，今年迄今为止下跌了 30.7%。8月6日 - 预测变化   * 过去三个月，分析师的平均盈利预测下降了约 33.3%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Anavex 生命科学公司 12 个月目标价的中位数为 40.45 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Anavex 生命科学公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2457028878","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅拉升5.58%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028878","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028878?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:32","pubTimestamp":1722951139,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时32分，Anavex Life Sciences Corp.股票出现异动，股价大幅上涨5.58%。截至发稿，该股报6.81美元/股，成交量2.9972万股，换手率0.04%，振幅1.55%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.31%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213219af96334e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213219af96334e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2456993280","title":"Anavex Life Sciences Corp    预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456993280","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456993280?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:20","pubTimestamp":1722608427,"startTime":"0","endTime":"0","summary":"   * Anavex Life Sciences Corp    将于8月6日公布截至2024年6月30日的财报，预计季度营收将保持不变。*    * LSEG分析师对Anavex生命科学公司的平均预期是每股亏损16美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 3 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Anavex Life Sciences Corp 的 12 个月目标价中位数为 40.45 美元，高于其上次收盘价 6.58 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Anavex Life Sciences Corp    预计每股亏损 16 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL"],"gpt_icon":0},{"id":"2456281246","title":"Anavex Life Sciences Corp.盘中异动 急速下挫5.62%报6.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281246","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281246?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.92%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2455109158","title":"Anavex Life Sciences Corp.盘中异动 早盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455109158","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455109158?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:43","pubTimestamp":1722436981,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日22时43分，Anavex Life Sciences Corp.股票出现波动，股价急速拉升5.15%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为1.02%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731224301af9525e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731224301af9525e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2455305439","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455305439","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455305439?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:44","pubTimestamp":1722347044,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时44分，Anavex Life Sciences Corp.股票出现异动，股价快速跳水5.26%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.67%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214405aefc3405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214405aefc3405&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2455663189","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663189","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663189?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:31","pubTimestamp":1722259880,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时31分，Anavex Life Sciences Corp.股票出现异动，股价急速拉升5.04%。截至发稿，该股报7.08美元/股，成交量35.9262万股，换手率0.42%，振幅3.41%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.02%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213120aefbf9c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213120aefbf9c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2454687245","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454687245","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454687245?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:21","pubTimestamp":1721917272,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时21分，Anavex Life Sciences Corp.股票出现波动，股价急速上涨5.26%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.94%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222112941faa3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222112941faa3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2453037000","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.08%报6.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453037000","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453037000?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:45","pubTimestamp":1721742307,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时45分，Anavex Life Sciences Corp.股票出现异动，股价大幅拉升5.08%。截至发稿，该股报6.21美元/股，成交量15.8065万股，换手率0.19%，振幅5.92%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.31%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214507aefb026d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214507aefb026d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2453791257","title":"Anavex Life Sciences Corp.盘中异动 早盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453791257","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453791257?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:57","pubTimestamp":1721660274,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时57分，Anavex Life Sciences Corp.股票出现异动，股价急速上涨5.02%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.99%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222257549681eead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222257549681eead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2453764344","title":"Anavex Life Sciences(AVXL.US)获EF Hutton首次覆盖，给予买入评级, 目标价46.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453764344","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453764344?lang=zh_cn&edition=full","pubTime":"2024-07-22 20:20","pubTimestamp":1721650857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AVXL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anavex.com","stockEarnings":[{"period":"1week","weight":0.0378},{"period":"1month","weight":-0.0217},{"period":"3month","weight":0.58},{"period":"6month","weight":0.2846},{"period":"1year","weight":-0.1845},{"period":"ytd","weight":-0.3212}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anavex Life Sciences Corp.成立于2004年1月23日，位于内华达州。是一家临床阶段的生物制药公司，致力于开发差异化疗法，将精准医学应用于高度未满足需求的中枢神经系统（CNS）疾病。该公司目前有两个核心计划和两个种子计划。该公司的核心计划处于神经退行性疾病和神经发育疾病的临床和临床前开发的各个阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.035298},{"month":2,"riseRate":0.555556,"avgChangeRate":0.165719},{"month":3,"riseRate":0.555556,"avgChangeRate":0.075509},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.092651},{"month":5,"riseRate":0.777778,"avgChangeRate":0.060811},{"month":6,"riseRate":0.666667,"avgChangeRate":0.162785},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.058369},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.01961},{"month":9,"riseRate":0.625,"avgChangeRate":0.029685},{"month":10,"riseRate":0.5,"avgChangeRate":-0.012082},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.025321},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.038868}],"exchange":"NASDAQ","name":"Anavex Life Sciences Corp.","nameEN":"Anavex Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anavex Life Sciences Corp.,AVXL,Anavex Life Sciences Corp.股票,Anavex Life Sciences Corp.股票老虎,Anavex Life Sciences Corp.股票老虎国际,Anavex Life Sciences Corp.行情,Anavex Life Sciences Corp.股票行情,Anavex Life Sciences Corp.股价,Anavex Life Sciences Corp.股市,Anavex Life Sciences Corp.股票价格,Anavex Life Sciences Corp.股票交易,Anavex Life Sciences Corp.股票购买,Anavex Life Sciences Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}